13F Holdings
中文EN

WGS GeneDx Holdings Corp.

Services-Health Services · Nasdaq · SEC CIK 1818331 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY14.6%
TTM net income YoY-5,431.2%
TTM EPS YoY-3,518.2%
Revenue 3-yr CAGR30.7%
Net income 3-yr CAGR—

Margins

Gross margin68.7%
Operating margin-21.6%
Net margin-24.1%
FCF margin-22.0%
EBITDA margin-19.0%

Returns

ROE-41.4%
ROA-21.8%
ROIC (approx.)-29.0%
Asset turnover0.90x

Leverage & solvency

Liabilities / assets53.5%
Debt / equity0.60x
Current ratio4.16x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.68x
Accruals ratio-7.1%
Payout ratio—
Capex / revenue5.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$427.54M$305.45M$202.57M$234.69M$212.19M
Cost of revenue$129.37M$111.05M$112.56M$261.44M$228.80M
Gross profit$298.17M$194.40M$90.01M-$26.75M-$16.60M
R&D expense$72.03M$45.72M$58.27M$86.20M$105.16M
SG&A expense$150.82M$104.52M$139.02M$216.17M$205.99M
Operating income-$13.08M-$23.21M-$180.60M-$667.65M-$446.15M
Interest expense———$3.21M$2.83M
Pretax income-$21.14M-$52.63M-$176.69M-$598.03M-$245.39M
Income tax-$116,000-$343,000-$926,000-$49.05M$0
Net income-$21.02M-$52.29M-$175.77M-$548.98M-$245.39M
EBITDA-$3.48M-$15.31M-$160.90M-$617.65M-$424.34M
EPS (basic)-0.73-1.94-7.23-53.63-2.27
EPS (diluted)-0.73-1.94-7.23-53.63-2.27
Weighted avg. shares (diluted)28.64M26.89M24.31M10.24M108.08M
Banking
Net interest income——$1.11M-$666,000—
Balance sheet
Cash & equivalents$105.00M$86.20M$100.67M$138.30M$401.47M
Short-term investments$66.28M$55.97M$30.47M$0—
Receivables$74.37M$37.63M—$42.63M$26.51M
Inventory$13.95M$10.65M$8.78M$13.66M$33.46M
Current assets$268.29M$197.97M$182.34M$212.62M$483.54M
PP&E, net$45.69M$32.89M$32.48M$51.53M$62.72M
Goodwill$13.52M$0——$0
Intangibles$168.48M$158.60M$172.62M$186.65M$0
Total assets$523.71M$419.38M$418.76M$490.94M$554.09M
Current liabilities$108.91M$54.82M$58.82M$144.30M$101.28M
Short-term debt$4.54M$1.21M$497,000$4.75M$0
Long-term debt$48.18M$51.91M$52.69M$6.25M$11.00M
Total debt$52.72M$53.12M$53.19M$11.00M$11.00M
Total liabilities$215.53M$174.13M$190.74M$237.24M$165.99M
Shareholders' equity$308.18M$245.25M$228.02M$253.71M$388.10M
Net debt-$52.28M-$33.08M-$47.48M-$127.30M-$390.47M
Shares outstanding29.25M28.02M25.98M11.77M242.65M
Cash flow statement
Operating cash flow$33.28M-$28.50M-$180.15M-$319.15M-$190.43M
Capital expenditure$19.02M$5.49M$5.25M$7.16M$9.40M
Free cash flow$14.26M-$33.99M-$185.40M-$326.31M-$199.83M
Investing cash flow-$61.52M-$30.13M-$43.73M-$141.33M-$20.79M
Financing cash flow$48.02M$44.16M$186.24M$197.31M$493.73M
Depreciation & amortization$9.60M$7.90M$19.70M$50.00M$21.81M
Stock-based compensation$32.16M$9.14M-$326,000$41.98M$219.42M

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.